Licensed Practical Nurse in Lawrence, KS Accepting Medicare

4 Licensed Practical Nurse nurses found. Showing 1 - 4

Victoria Rae Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2415 Massachusetts St, Lawrence, KS 66046 Phone: 785-843-3750    Fax: 785-832-4887

Bonnie Jean Buzzard, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2412 Lancaster Dr, Lawrence, KS 66049 Phone: 785-727-8985

Mrs. Jammie Lynn Hedrick, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4821 Quail Crest Pl, Lawrence, KS 66049 Phone: 785-350-4650    Fax: 785-350-4666

Sonja Defoe, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 712 Shelburn Pl, Lawrence, KS 66046 Phone: 785-766-6477

News Archive

NAFC honors VUMC nurse practitioner with Rodney Appell Continence Care Champion Award

The National Association For Continence (NAFC) presented Margaret "Amy" Hull, RNC, MSN, WHCNP, with its Rodney Appell Continence Care Champion Award at the Society of Urologic Nurses and Associates (SUNA) annual awards luncheon on March 3, 2012 held during the 2012 SUNA Annual Symposium in San Francisco.

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit on Saturday, October 1, 2011.

Impulse control disorders found to be more common in people taking Parkinson's drugs

Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a study published in the June 20, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Novel therapy gets FDA approval for patients with metastatic pancreatic adenocarcinoma

Today, The U.S. Food and Drug Administration approved a novel therapy for patients with metastatic pancreatic adenocarcinoma – the most common form of pancreatic cancer – whose disease has progressed following gemcitabine-based therapy, offering new hope against a disease that will claim the lives of more than 40,000 individuals this year.

Read more Medical News

› Verified 8 days ago